Sunday, December 3, 2023
Osteoarthritis (OA) is a progressive disease that inevitably worsens with time. OA-related pain substantially impairs patients’ quality of life. OA management primarily focuses on symptomatic relief through the use of nonpharmacologic and pharmacologic interventions. However, these interventions often fall short of providing pain relief. Research into the pathophysiology of pain has led to the development of novel targeted therapies for use in patients with knee OA.
The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been authorized by the European Medicines Agency for use in Europe, off-label uses of authorized products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.
Medscape Education© WebMD Global, LLC
Join our expert faculty as they discuss recent updates in osteoarthritis patient care.
Join our faculty expert as he explores current therapeutic options for chronic osteoarthritis pain, and targeted therapies
on the horizon.
Join our expert faculty as they discuss the assessment and treatment of chronic osteoarthritis pain, including new targeted
therapies.